Longitudinal monitoring of disease burden and response using ctDNA from dried blood spots in xenograft models
Abstract Whole‐genome sequencing (WGS) of circulating tumour DNA (ctDNA) is now a clinically important biomarker for predicting therapy response, disease burden and disease progression. However, the translation of ctDNA monitoring into vital preclinical PDX models has not been possible owing to low...
Saved in:
| Main Authors: | Carolin M Sauer, Katrin Heider, Jelena Belic, Samantha E Boyle, James A Hall, Dominique‐Laurent Couturier, Angela An, Aadhitthya Vijayaraghavan, Marika AV Reinius, Karen Hosking, Maria Vias, Nitzan Rosenfeld, James D Brenton |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2022-06-01
|
| Series: | EMBO Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/emmm.202215729 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cancer phylogenetic tree inference at scale from 1000s of single cell genomes
by: Salehi, Sohrab, et al.
Published: (2023-07-01) -
Evaluation of Clinically Relevant Markers in a Patient-Derived Xenograft Model of Triple-Negative Breast Cancer
by: I. S. Lyashenko, et al.
Published: (2025-05-01) -
Approaches to modeling cancer metastasis: from bench to bedside
by: Leiyu Sun, et al.
Published: (2025-08-01) -
PDX models recapitulate the genetic and epigenetic landscape of pediatric T‐cell leukemia
by: Paulina Richter‐Pechańska, et al.
Published: (2018-11-01) -
Intraductal xenografts show lobular carcinoma cells rely on their own extracellular matrix and LOXL1
by: George Sflomos, et al.
Published: (2021-02-01)